MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/coa.70103

Медицинская библиотека · Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026

Oncological Outcomes for Primary Head and Neck Squamous Cell Carcinoma in the United Kingdom: Results From a National Cross-Sectional Cohort Study.

Green Frederick R, Williamson Andrew, Lim Alison E, Lee Ying Ki, Li Lucy, Moen Christy, Vasanthan Rishi, Wharf Olivia, Wong Jeremy, Paleri Vinidh, INTEGRATE Collaborators

СтатьяНаблюдательное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To investigate overall survival outcomes from primary head and neck squamous cell carcinoma (HNSCC) in the UK.

DESIGN

A retrospective national observational cohort study with consecutive participants.

SETTING

UK-wide head and neck cancer centres.

PARTICIPANTS

All patients with HNSCC who received a definitive treatment decision between 01/09/2021 and 30/11/2021. Subgroup analysis of patients was stratified by head and neck subsites.

MAIN OUTCOME MEASURES: Two-year overall (OS), disease-free (DFS), disease-specific (DSS), and local-recurrence-free-survival (LRFS) from primary HNSCC.

RESULTS

Data from 1488 patients was submitted by 50 centres, of which 1286 were primary HNSCC. Median age was 65.5 years (IQR 57-74), and 911 (71.0%) were male. The most common subsites were oropharynx (37.6%), oral cavity (28.3%), larynx (22.0%), and hypopharynx (6.8%). Treatment intent was curative in 79.9% of cases. Of treatment modalities, 529 (41.3%) underwent surgery, 874 (68.4%) underwent radiotherapy, and 391 (30.7%) underwent chemotherapy. Two-year OS, DFS, DSS and LRFS were 79.7%, 72.2%, 84.8%, and 75.1%, respectively. Two-year OS was 83.5%, 55.4%, 73.9% and 84.6% for laryngeal, hypopharyngeal, oral cavity and oropharyngeal subsites, respectively. On multivariate analysis, clinical T staging, age, ECOG performance status, and p16 status were independent prognostic factors for survival.

CONCLUSION

UK survival variations according to disease subsite reflect larger studies. Broader data over larger periods will reveal whether long-term improvements in the diagnosis, biological understanding, and treatments of HNSCC have translated into improvements in UK survival outcomes.

Для цитирования: Green Frederick R, Williamson Andrew, Lim Alison E, Lee Ying Ki, Li Lucy, Moen Christy, Vasanthan Rishi, Wharf Olivia, Wong Jeremy, Paleri Vinidh, INTEGRATE Collaborators. Oncological Outcomes for Primary Head and Neck Squamous Cell Carcinoma in the United Kingdom: Results From a National Cross-Sectional Cohort Study.. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2026. DOI: 10.1111/coa.70103.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.